PRTA
Closed
Prothena Corporation Plc
6.26
+0.19 (+3.13%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 6.07
Day's Range: 5.96 - 6.49
Send
sign up or login to leave a comment!
When Written:
48.84
Prothena Corporation plc is a clinical-stage biotechnology company that focuses on the discovery and development of novel therapies for the treatment of neurodegenerative diseases. The company was founded in 2012 and is headquartered in Dublin, Ireland.
Prothena's pipeline includes several potential treatments for diseases such as Alzheimer's, Parkinson's, and ALS. The company's lead candidate, PRX002, is a monoclonal antibody designed to target alpha-synuclein, a protein that is believed to play a key role in the development of Parkinson's disease. Prothena is also developing potential therapies for amyloidosis, a group of rare diseases that occur when abnormal proteins build up in organs and tissues.
In addition to its drug development efforts, Prothena has also established partnerships with other biotechnology and pharmaceutical companies, including Celgene, Roche, and Bristol Myers Squibb.
Prothena is publicly traded on the NASDAQ stock exchange under the ticker symbol PRTA.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Prothena's pipeline includes several potential treatments for diseases such as Alzheimer's, Parkinson's, and ALS. The company's lead candidate, PRX002, is a monoclonal antibody designed to target alpha-synuclein, a protein that is believed to play a key role in the development of Parkinson's disease. Prothena is also developing potential therapies for amyloidosis, a group of rare diseases that occur when abnormal proteins build up in organs and tissues.
In addition to its drug development efforts, Prothena has also established partnerships with other biotechnology and pharmaceutical companies, including Celgene, Roche, and Bristol Myers Squibb.
Prothena is publicly traded on the NASDAQ stock exchange under the ticker symbol PRTA.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!